Bibliography

Found 17 results

Filters: Author is Justin C McArthur [Clear All Filters]

Miscellaneous

McArthur JC. Center for novel therapeutics for HIV-associated cognitive disorders. 2011 .

Journal Article

Joseph J, Clifford DB, Douglas SD, Fox HS, Gendelman HE, Gonzalez-Scarano F, Grant I, Major E, McArthur JC. Planning Future Strategies for Domestic and International NeuroAIDS Research, July 24-25, 2008. Journal of NeuroImmune Pharmacology [Internet]. 2009 ;4(3):283-297. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19455426

Brown A, Islam T, Adams R, Nerle S, Kamara M, Eger C, Marder K, Cohen BA, Schifitto G, McArthur JC, et al. Osteopontin enhances HIV replication and is increased in the brain and cerebrospinal fluid of HIV-infected individuals. Journal of NeuroVirology [Internet]. 2011 ;17(4):382-392. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21556958

Marra CM, Deutsch R, Collier AC, Morgello S, Letendre S, Clifford DB, Gelman B, McArthur JC, McCutchan JA, Simpson DM, et al. Neurocognitive impairment in HIV-infected individuals with previous syphilis. Int J STD AIDS. 2013 ;24(5):351-5.

Chauhan A, Hahn S, Gartner S, Pardo C, Netesan SK, McArthur JC, Nath A. Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statins. The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology [Internet]. 2007 ;21:777-89. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17197385

Ubaida-Mohien C, Lamberty B, Dickens AM, Mielke MM, Marcotte TD, Sacktor N, Grant I, Letendre S, Franklin D, Cibrowski P, et al. Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients. AIDS. 2017 ;31(10):1365-1378.

Bandaru VVenkata Ra, Mielke MM, Sacktor N, McArthur JC, Grant I, Letendre S, Chang L, Wojna V, Pardo C, Calabresi P, et al. A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects. Neurology. 2013 ;81(17):1492-9.

Fennema-Notestine C, Ellis RJ, Archibald SL, Jernigan TL, Letendre S, Notestine RJ, Taylor MJ, Theilmann RJ, Julaton MD, Croteau D, et al. Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. J Neurovirol. 2013 ;19(4):393-401.

Nguyen A, Rossi S, Croteau D, Best BM, Clifford DB, Collier AC, Gelman B, Marra C, McArthur JC, McCutchan JA, et al. Etravirine in CSF is highly protein bound. J Antimicrob Chemother. 2013 ;68(5):1161-8.

Livelli A, Vaida F, Ellis RJ, Ma Q, Ferrara M, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, et al. Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study. Lancet HIV. 2019 ;6(7):e456-e462.

Sakamoto M, Marcotte TD, Umlauf A, Franklin D, Heaton RK, Ellis RJ, Letendre S, Alexander T, McCutchan JA, Morgan EE, et al. Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr. 2013 ;62(1):36-42.

Ellis RJ, Evans SR, Clifford DB, Moo LR, McArthur JC, Collier AC, Benson C, Bosch R, Simpson DM, Yiannoutsos CT, et al. Clinical validation of the NeuroScreen. Journal of Neurovirology [Internet]. 2005 ;11(6):503-11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16338744

Brown A, Sacktor N, Marder K, Cohen BA, Schifitto G, Skolasky RL, Creighton J, Guo L, McArthur JC. CCL3L1 gene copy number in individuals with and without HIV-associated neurocognitive disorder. Journal of Current Biomarker Findings [Internet]. 2012 ;2012(2):1-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23814703

Grant I, Franklin D, Deutsch R, Woods SPaul, Vaida F, Ellis RJ, Letendre S, Marcotte TD, Atkinson JH, Collier AC, et al. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014 ;82(23):2055-62.

Morgan EE, Woods SPaul, Letendre S, Franklin D, Bloss C, Goate A, Heaton RK, Collier AC, Marra CM, Gelman B, et al. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neurovirol. 2013 ;19(2):150-6.

Clifford DB, Vaida F, Kao Y-ting, Franklin D, Letendre S, Collier AC, Marra CM, Gelman B, McArthur JC, Morgello S, et al. Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people. Neurology. 2015 ;84(3):241-50.

Conference Paper

Brown A, Skolasky RL, Marder K, Cohen BA, Schifito G, Creighton J, Guo L, McArthur JC. CCL3L1 gene copy number in the Northeast AIDS Dementia (NEAD) Cohort and the National NeuroAIDS Tissue Consortium (NNTC). In: Conference on Retroviruses. Conference on Retroviruses. ; 2009.